Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Bioconjugate Chemistry
|
May 22, 2003
A novel method for the rational construction of well-defined immunogens: the use of oximation to conjugate cholera toxin B subunit to a peptide-polyoxime complex
Jianhua Chen, Weiguang Zeng, Robin Offord, et al.
AIDS Research and Human Retroviruses
|
February 9, 2017
Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage
Fabrice Cerini, Robin Offord, Ian McGowan, et al.
Pharmacy World & Science : PWS
|
September 28, 2004
Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients
Robin Offord, Adam C Lloyd, Pippa Anderson, et al.
Future Healthcare Journal
|
October 23, 2020
Establishing a service to tackle problematic polypharmacy
Frances Bennett, Neha Shah, Robin Offord, et al.
Bioconjugate Chemistry
|
January 9, 2008
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein
Hubert Gaertner, Robin Offord, Paolo Botti, et al.
Journal of Proteomics
|
May 22, 2009
Comparative proteomic study of the venom of the piscivorous cone snail Conus consors
Daniel Biass, Sébastien Dutertre, Alain Gerbault, et al.
AAPS Pharmscitech
|
March 18, 2015
Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation
Karine Fabio, Kieran Curley, Joseph Guarneri, et al.
The Journal of Infectious Diseases
|
April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge
Ronald S Veazey, Binhua Ling, Linda C Green, et al.
Protein Engineering, Design & Selection : PEDS
|
January 8, 2008
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4
Hubert Gaertner, Olivier Lebeau, Irène Borlat, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2008
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide
Hubert Gaertner, Fabrice Cerini, Jean-Michel Escola, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Bioconjugate Chemistry
|
May 22, 2003
A novel method for the rational construction of well-defined immunogens: the use of oximation to conjugate cholera toxin B subunit to a peptide-polyoxime complex
Jianhua Chen, Weiguang Zeng, Robin Offord, et al.
AIDS Research and Human Retroviruses
|
February 9, 2017
Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage
Fabrice Cerini, Robin Offord, Ian McGowan, et al.
Pharmacy World & Science : PWS
|
September 28, 2004
Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients
Robin Offord, Adam C Lloyd, Pippa Anderson, et al.
Future Healthcare Journal
|
October 23, 2020
Establishing a service to tackle problematic polypharmacy
Frances Bennett, Neha Shah, Robin Offord, et al.
Bioconjugate Chemistry
|
January 9, 2008
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein
Hubert Gaertner, Robin Offord, Paolo Botti, et al.
Journal of Proteomics
|
May 22, 2009
Comparative proteomic study of the venom of the piscivorous cone snail Conus consors
Daniel Biass, Sébastien Dutertre, Alain Gerbault, et al.
AAPS Pharmscitech
|
March 18, 2015
Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation
Karine Fabio, Kieran Curley, Joseph Guarneri, et al.
The Journal of Infectious Diseases
|
April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge
Ronald S Veazey, Binhua Ling, Linda C Green, et al.
Protein Engineering, Design & Selection : PEDS
|
January 8, 2008
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4
Hubert Gaertner, Olivier Lebeau, Irène Borlat, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 14, 2008
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide
Hubert Gaertner, Fabrice Cerini, Jean-Michel Escola, et al.
Page
of 2